These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38273472)

  • 21. Allopurinol use and type 2 diabetes incidence among patients with gout: A VA retrospective cohort study.
    Slobodnick A; Toprover M; Greenberg J; Crittenden DB; Pike VC; Qian Y; Zhong H; Pillinger MH
    Medicine (Baltimore); 2020 Aug; 99(35):e21675. PubMed ID: 32871882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-gout Medications and Risk of Cardiovascular Disease: A Nested Case-Control Study.
    Chuang TJ; Wang YH; Wei JC; Yeh CJ
    Front Med (Lausanne); 2021; 8():739680. PubMed ID: 34733863
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-Term Follow-up of a Randomized Controlled Trial of Allopurinol Dose Escalation to Achieve Target Serum Urate in People With Gout.
    Coleman GB; Dalbeth N; Frampton C; Haslett J; Drake J; Su I; Horne AM; Stamp LK
    J Rheumatol; 2022 Dec; 49(12):1372-1378. PubMed ID: 35777814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired response or insufficient dosage? Examining the potential causes of "inadequate response" to allopurinol in the treatment of gout.
    Stamp LK; Merriman TR; Barclay ML; Singh JA; Roberts RL; Wright DF; Dalbeth N
    Semin Arthritis Rheum; 2014 Oct; 44(2):170-4. PubMed ID: 24925693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opportunities for improving medication use and monitoring in gout.
    Singh JA; Hodges JS; Asch SM
    Ann Rheum Dis; 2009 Aug; 68(8):1265-70. PubMed ID: 18701554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gout characteristics associate with depression, but not anxiety, in primary care: Baseline findings from a prospective cohort study.
    Prior JA; Mallen CD; Chandratre P; Muller S; Richardson J; Roddy E
    Joint Bone Spine; 2016 Oct; 83(5):553-8. PubMed ID: 27068619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of allopurinol and febuxostat for the management of gout.
    Jutkowitz E; Choi HK; Pizzi LT; Kuntz KM
    Ann Intern Med; 2014 Nov; 161(9):617-26. PubMed ID: 25364883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medication adherence among patients with gout: A systematic review and meta-analysis.
    Scheepers LEJM; van Onna M; Stehouwer CDA; Singh JA; Arts ICW; Boonen A
    Semin Arthritis Rheum; 2018 Apr; 47(5):689-702. PubMed ID: 29198878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.
    Dalbeth N; Kumar S; Stamp L; Gow P
    J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potency on lowering serum uric acid in gout patients: a pooled analysis of registrative studies comparing febuxostat vs. allopurinol.
    Cutolo M; Cimmino MA; Perez-Ruiz F
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4186-4195. PubMed ID: 29028079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. More allopurinol is needed to get gout patients < 0.36 mmol/l: a gout audit in the form of a before-after trial.
    Arroll B; Bennett M; Dalbeth N; Hettiarachchi D; Ben C; Shelling G
    J Prim Health Care; 2009 Dec; 1(4):315-8. PubMed ID: 20690341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Perspectives in Rheumatology: Implications of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial and the Associated Food and Drug Administration Public Safety Alert.
    Choi H; Neogi T; Stamp L; Dalbeth N; Terkeltaub R
    Arthritis Rheumatol; 2018 Nov; 70(11):1702-1709. PubMed ID: 29869840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adherence with urate-lowering therapies for the treatment of gout.
    Harrold LR; Andrade SE; Briesacher BA; Raebel MA; Fouayzi H; Yood RA; Ockene IS
    Arthritis Res Ther; 2009; 11(2):R46. PubMed ID: 19327147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful use of allopurinol in a patient on dialysis.
    Day RO; Kannangara DR; Hayes JM; Furlong TJ
    BMJ Case Rep; 2012 Jun; 2012():. PubMed ID: 22675142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An allopurinol adherence tool using plasma oxypurinol concentrations.
    Smith-Diaz N; Stocker SL; Stamp LK; Dalbeth N; Phipps-Green AJ; Merriman TR; Wright DFB
    Br J Clin Pharmacol; 2023 Jul; 89(7):1956-1964. PubMed ID: 36036094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. General practitioners' perspectives on the management of gout: a qualitative study.
    Jeyaruban A; Soden M; Larkins S
    Postgrad Med J; 2016 Oct; 92(1092):603-7. PubMed ID: 27033862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistence with urate-lowering therapy in Australia: A longitudinal analysis of allopurinol prescriptions.
    Coleshill MJ; Day RO; Tam K; Kouhkamari M; Caillet V; Aung E; Kannangara DRW; Cronin P; Rodgers A; Stocker SL
    Br J Clin Pharmacol; 2022 Nov; 88(11):4894-4901. PubMed ID: 35675118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rationale and design of the randomized evaluation of an Ambulatory Care Pharmacist-Led Intervention to Optimize Urate Lowering Pathways (RAmP-UP) Study.
    Coburn BW; Cheetham TC; Rashid N; Chang JM; Levy GD; Kerimian A; Low KJ; Redden DT; Bridges SL; Saag KG; Curtis JR; Mikuls TR
    Contemp Clin Trials; 2016 Sep; 50():106-15. PubMed ID: 27449546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting Response or Non-response to Urate-Lowering Therapy in Patients with Gout.
    Graham GG; Stocker SL; Kannangara DRW; Day RO
    Curr Rheumatol Rep; 2018 Jun; 20(8):47. PubMed ID: 29931553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors Influencing Allopurinol Initiation in Primary Care.
    Clarson LE; Hider SL; Belcher J; Roddy E; Mallen CD
    Ann Fam Med; 2017 Nov; 15(6):557-560. PubMed ID: 29133496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.